Novel insights into P450 BM3 interactions with FDA-approved antifungal azole drugs. (2019)

First Author: Jeffreys LN
Attributed to:  Molecular reconstruction of flavocytochrome P450 BM3 funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-018-37330-y

PubMed Identifier: 30733479

Publication URI: http://europepmc.org/abstract/MED/30733479

Type: Journal Article/Review

Volume: 9

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322